Resultados: 37
#1
au:Medeiros Neto, Eduardo
Filtros
Ordenar por
Página
de 3
Próxima
1.
Joint statement on evidence-based practices in mechanical ventilation: suggestions from two Brazilian medical societies
Facebook Twitter

Facebook Twitter
- Outras redes sociais
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Outras redes
- Métricas
Ferreira, Juliana Carvalho
; Vianna, Arthur Oswaldo de Abreu
; Pinheiro, Bruno Valle
; Maia, Israel Silva
; Baldisserotto, Sérgio Vasconcellos
; Isola, Alexandre Marini
; Cavalcanti, Alexandre Biasi
Gama, Ana Maria Casati Nogueira da
Rocha, Angelo Roncalli Miranda
Oliveira, Antonio Gonçalves de
Serpa Neto, Ary
Farias, Augusto Manoel de Carvalho
Orlando, Bianca Rodrigues
Esteves, Bruno da Costa
Mazza, Bruno Franco
Silveira, Camila de Freitas Martins Soares
Carvalho, Carlos Roberto Ribeiro de
Toufen Junior, Carlos
Barbas, Carmen Silvia Valente
Teixeira, Cassiano
Silveira, Débora Dutra da
Medeiros, Denise Machado
Parolo, Edino
Costa, Eduardo Leite Vieira
Caser, Eliana Bernadete
Oliveira, Ellen Pierre de
Banholzer, Eric Grieger
Carvalho, Erich Vidal
Amorim, Fabio Ferreira
Saddy, Felipe
Gonçalves, Fernanda Alves Ferreira
Galas, Filomena Regina Barbosa Gomes
Zanatta, Giovanna Carolina Gardini
Silva, Gisele Sampaio
Westphal, Glauco Adrieno
Matos, Gustavo Faissol Janot de
Souza, João Claudio Emmerich de
Silva Junior, João Manoel
Valiatti, Jorge Luis dos Santos
Nascimento Junior, José Ribamar do
Rocco, Jose Rodolfo
Hajjar, Ludhmila Abrahão
Forgiarini Junior, Luiz Alberto
Malbuisson, Luiz Marcelo Sá
Holanda, Marcelo Alcantara
Amato, Marcelo Britto Passos
Park, Marcelo
Oliveira, Marco Antonio da Rosa e
Reis, Marco Antonio Soares
Tavares, Marcos Soares
Souza, Mario Henrique Dutra de
Damasceno, Marta Cristina Pauleti
Lira-Batista, Marta Maria da Silva
Pattacini, Max Morais
Assunção, Murillo Santucci Cesar de
Oliveira, Neymar Elias de
Franzosi, Oellen Stuani
Rocco, Patricia Rieken Macedo
Caruso, Pedro
Silva, Pedro Leme
Mendes, Pedro Vitale
Duarte, Pericles Almeida Delfino
Santa Neto, Renato Fabio Alberto Della
Rodrigues, Ricardo Goulart
Cordioli, Ricardo Luiz
Palazzo, Roberta Fittipaldi
Goldwasser, Rosane
Pinheiro, Sabrina dos Santos
Justino, Sandra Regina
Nemer, Sergio Nogueira
Oliveira, Vanessa Martins de
Silva, Vinicius Zacarias Maldaner da
Nedel, Wagner Luis
Bellissimo-Rodrigues, Wanessa Teixeira
Oliveira Filho, Wilson de






ABSTRACT Mechanical ventilation can be a life-saving intervention, but its implementation requires a multidisciplinary approach, with an understanding of its indications and contraindications due to the potential for complications. The management of mechanical ventilation should be part of the curricula during clinical training; however, trainees and practicing professionals frequently report low confidence in managing mechanical ventilation, often seeking additional sources of knowledge. Review articles, consensus statements and clinical practice guidelines have become important sources of guidance in mechanical ventilation, and although clinical practice guidelines offer rigorously developed recommendations, they take a long time to develop and can address only a limited number of clinical questions. The Associação de Medicina Intensiva Brasileira and the Sociedade Brasileira de Pneumologia e Tisiologia sponsored the development of a joint statement addressing all aspects of mechanical ventilation, which was divided into 38 topics. Seventy-five experts from all regions of Brazil worked in pairs to perform scoping reviews, searching for publications on their specific topic of mechanical ventilation in the last 20 years in the highest impact factor journals in the areas of intensive care, pulmonology, and anesthesiology. Each pair produced suggestions and considerations on their topics, which were presented to the entire group in a plenary session for modification when necessary and approval. The result was a comprehensive document encompassing all aspects of mechanical ventilation to provide guidance at the bedside. In this article, we report the methodology used to produce the document and highlight the most important suggestions and considerations of the document, which has been made available to the public in Portuguese.
2.
Brazilian Guideline on Menopausal Cardiovascular Health – 2024 202 20 2
Facebook Twitter

Facebook Twitter
- Outras redes sociais
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Outras redes
- Métricas
Oliveira, Gláucia Maria Moraes de
; Almeida, Maria Cristina Costa de
; Arcelus, Carolina María Artucio
; Espíndola Neto, Larissa
; Rivera, Maria Alayde Mendonça
; Silva-Filho, Agnaldo Lopes da
; Marques-Santos, Celi
; Fernandes, César Eduardo
; Albuquerque, Carlos Japhet da Matta
; Freire, Claudia Maria Vilas
; Izar, Maria Cristina de Oliveira
; Costa, Maria Elizabeth Navegantes Caetano
; Castro, Marildes Luiza de
; Lemke, Viviana de Mello Guzzo
; Lucena, Alexandre Jorge Gomes de
; Brandão, Andréa Araujo
; Macedo, Ariane Vieira Scarlatelli
; Polanczyk, Carisi Anne
; Lantieri, Carla Janice Baister
; Nahas, Eliana Petri
; Alexandre, Elizabeth Regina Giunco
; Campana, Erika Maria Gonçalves
; Bragança, Érika Olivier Vilela
; Colombo, Fernanda Marciano Consolim
; Barbosa, Imara Correia de Queiroz
; Rivera, Ivan Romero
; Kulak, Jaime
; Moura, Lidia Ana Zytynski
; Pompei, Luciano de Mello
; Baccaro, Luiz Francisco Cintra
; Barbosa, Marcia Melo
; Rodrigues, Marcio Alexandre Hipólito
; Albernaz, Marco Aurelio
; Decoud, Maria Sotera Paniagua de
; Paiva, Maria Sanali Moura de Oliveira
; Sanchez-Zambrano, Martha Beatriz
; Campos, Milena dos Santos Barros
; Acevedo, Monica
; Ramirez, Monica Susana
; Souza, Olga Ferreira de
; Medeiros, Orlando Otávio de
; Carvalho, Regina Coeli Marques de
; Machado, Rogerio Bonassi
; Silva, Sheyla Cristina Tonheiro Ferro da
; Rodrigues, Thais de Carvalho Vieira
; Avila, Walkiria Samuel
; Costa-Paiva, Lucia Helena Simões da
; Wender, Maria Celeste Osorio
.
















































Revista Brasileira de Ginecologia e Obstetrícia
- Métricas do periódico
3.
Fear of Childbirth: cross-cultural adaptation of the Wijma Delivery Experience Questionnaire version B in Brazilian Portuguese and cross-sectional study Childbirth crosscultural cross cultural crosssectional sectional
Facebook Twitter

Facebook Twitter
- Outras redes sociais
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Outras redes
- Métricas
Bergamini, Luna Lira
; Silva, Pedro Henrique do Nascimento
; Barretto Filho, Eduardo Pereira
; Costa, Auxiliadora Damianne Pereira Vieira da
; Melo Neto, Valfrido Leão de
; Medeiros, Mércia Lamenha
.






Revista Brasileira de Saúde Materno Infantil
- Métricas do periódico
Abstract Objectives: the present study aims to carry out a cross-cultural adaptation of the Wijma Delivery Expectancy/Experience Questionnaire Version B (WDEQ-B) into Brazilian Portuguese and apply it to a sample of Brazilian postpartum women, evaluating the prevalence of Fear of Childbirth (FoC) and possible associated factors. Methods: we conducted a cross-sectional study encompassing a process of translation and back-translation of the instrument followed by a pretesting phase. Results: we performed a cross-cultural adaptation of the WDEQ-B, with reasonable match from the original instrument and broadly comprehensible by our sample. 57 postpartum women were included, at three public maternity hospitals, finding a severe FoC prevalence of 10.6%. In addition, analyzing FoC and disruption between desired and actual delivery, a prevalence ratio of 10.8 (CI95%=1.3-87.7, p=0.026), was found. Conclusion: the WDEQ-B was successfully adapted to the Brazilian Portuguese and showed to be a linguistic and culturally comprehensible research tool to analyze FoC among postpartum women in our population. Moreover, the study showed that disruption between desired and actual delivery mode might be associated with FoC occurrence. Objectives crosscultural cross cultural ExpectancyExperience Expectancy Experience WDEQB WDEQ (WDEQ-B (FoC factors Methods crosssectional sectional backtranslation back phase Results WDEQB, B, 5 included hospitals 106 10 6 10.6% addition 108 8 10. CI95%=1.387.7, CI9513877 CI CI95%=1.3 87.7, CI95 1 3 87 7 (CI95%=1.3-87.7 p=0.026, p0026 p p=0.026 , 0 026 p=0.026) found Conclusion population Moreover occurrence 10.6 387 CI95%=1.387.7 CI951387 CI9513 CI95%=1. 877 87.7 CI9 (CI95%=1.3-87. p002 p=0.02 02 38 CI95%=1.387. CI95138 CI951 CI95%=1 87. (CI95%=1.3-87 p00 p=0.0 CI95%=1.387 CI95%= (CI95%=1.3-8 p0 p=0. CI95%=1.38 CI95% (CI95%=1.3- p=0 (CI95%=1.3 p= (CI95%=1. (CI95%=1 (CI95%= (CI95% (CI95 (CI9 (CI
Resumo Objetivos: o presente estudo objetiva realizar uma adaptação transcultural do Wijma Delivery Expectancy/ Experience Questionnaire versão B (WDEQ-B) para o português brasileiro e aplicá-lo numa amostra de puérperas brasileiras, avaliando a prevalência do medo do parto e possíveis fatores associados. Métodos: realizou-se um estudo transversal envolvendo um processo de tradução e retrotradução do instrumento seguido de uma fase de pré-teste. Resultados: foi realizada uma adaptação transcultural do WDEQ-B, com correspondência razoável com o instrumento original e amplamente compreensível pelas mulheres brasileiras. Foram incluídas 57puérperas, em três maternidades públicas, encontrando-se uma prevalência de 10,6%. Além disso, analisando-se a relação entre medo do parto e discordância entre preferência de via de parto e parto atual, foi encontrada uma razão de prevalência de 10,8 (IC95%= 1,3 – 87,7, p=0,026). Conclusão: o WDEQ-B foi adaptado com sucesso para o português brasileiro e se mostrou um instrumento de pesquisa linguisticamente e culturalmente compreensível para analisar o medo do parto. Além disso, o estudo mostrou que discordância entre preferência de via de parto e parto atual parece estar associada à maior ocorrência de medo severo do parto. Objetivos Expectancy WDEQB WDEQ (WDEQ-B aplicálo aplicá lo brasileiras associados Métodos realizouse realizou préteste. préteste pré teste. teste pré-teste Resultados WDEQB, B, 57puérperas públicas encontrandose encontrando 106 10 6 10,6% disso analisandose analisando 108 8 10, IC95%= IC95 IC (IC95% 13 1 3 1, 877 87 7 87,7 p=0,026. p0026 p p=0,026 . 0 026 p=0,026) Conclusão 10,6 IC95% IC9 (IC95 87, p002 p=0,02 02 (IC9 p00 p=0,0 (IC p0 p=0, p=0 p=
4.
Diretriz Brasileira de Dispositivos Cardíacos Eletrônicos Implantáveis – 2023 202 20 2
Facebook Twitter

Facebook Twitter
- Outras redes sociais
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Outras redes
- Métricas
Teixeira, Ricardo Alkmim
; Fagundes, Alexsandro Alves
; Baggio Junior, José Mário
; Oliveira, Júlio César de
; Medeiros, Paulo de Tarso Jorge
; Valdigem, Bruno Pereira
; Teno, Luiz Antônio Castilho
; Silva, Rodrigo Tavares
; Melo, Celso Salgado de
; Elias Neto, Jorge
; Moraes Júnior, Antonio Vitor
; Pedrosa, Anisio Alexandre Andrade
; Porto, Fernando Mello
; Brito Júnior, Hélio Lima de
; Souza, Thiago Gonçalves Schroder e
; Mateos, José Carlos Pachón
; Moraes, Luis Gustavo Belo de
; Forno, Alexander Romeno Janner Dal
; D’Avila, Andre Luiz Buchele
; Cavaco, Diogo Alberto de Magalhães
; Kuniyoshi, Ricardo Ryoshim
; Pimentel, Mauricio
; Camanho, Luiz Eduardo Montenegro
; Saad, Eduardo Benchimol
; Zimerman, Leandro Ioschpe
; Oliveira, Eduardo Bartholomay
; Scanavacca, Mauricio Ibrahim
; Martinelli Filho, Martino
; Lima, Carlos Eduardo Batista de
; Peixoto, Giselle de Lima
; Darrieux, Francisco Carlos da Costa
Duarte, Jussara de Oliveira Pinheiro
Galvão Filho, Silas dos Santos
Costa, Eduardo Rodrigues Bento
Mateo, Enrique Indalécio Pachón
Melo, Sissy Lara De
Rodrigues, Thiago da Rocha
Rocha, Eduardo Arrais
Hachul, Denise Tessariol
Lorga Filho, Adalberto Menezes
Nishioka, Silvana Angelina D’Orio
Gadelha, Eduardo Barreto
Costa, Roberto
Andrade, Veridiana Silva de
Torres, Gustavo Gomes
Oliveira Neto, Nestor Rodrigues de
Lucchese, Fernando Antonio
Murad, Henrique
Wanderley Neto, José
Brofman, Paulo Roberto Slud
Almeida, Rui M. S.
Leal, João Carlos Ferreira






























5.
Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this condition
Facebook Twitter

Facebook Twitter
- Outras redes sociais
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Outras redes
- Métricas
Silva, Clovis Artur
; Kupa, Leonard de Vinci Kanda
Medeiros-Ribeiro, Ana Cristina
Pasoto, Sandra Gofinet
Saad, Carla Gonçalves Schahin
Yuki, Emily Figueiredo Neves
Landim, Joaquim Ivo Vasques Dantas
Léda, Victor Hugo Ferreira e
Correia, Luisa Sacchi de Camargo
Sartori, Artur Fonseca
Martins, Carolina Campagnoli Machado Freire
Ribeiro, Carolina Torres
Waridel, Filipe
Martins, Victor Adriano de Oliveira
Shinjo, Samuel Katsuyuki
Andrade, Danieli Castro Oliveira
Sampaio-Barros, Percival Degrava
Borba Neto, Eduardo Ferreira
Aikawa, Nadia Emi
Bonfa, Eloisa

Abstract Background Data on post-acute COVID-19 in autoimmune rheumatic diseases (ARD) are scarce, focusing on a single disease, with variable definitions of this condition and time of vaccination. The aim of this study was to evaluate the frequency and pattern of post-acute COVID-19 in vaccinated patients with ARD using established diagnosis criteria. Methods Retrospective evaluation of a prospective cohort of 108 ARD patients and 32 non-ARD controls, diagnosed with SARS-CoV-2 infection (RT-PCR/antigen test) after the third dose of the CoronaVac vaccine. Post-acute COVID-19 (≥ 4 weeks and > 12 weeks of SARS-CoV-2 symptoms) were registered according to the established international criteria. Results ARD patients and non-ARD controls, balanced for age and sex, had high and comparable frequencies of ≥ 4 weeks post-acute COVID-19 (58.3% vs. 53.1%, p = 0.6854) and > 12 weeks post-acute COVID-19 (39.8% vs. 46.9%, p = 0.5419). Regarding ≥ 4 weeks post-acute COVID-19, frequencies of ≥ 3 symptoms were similar in ARD and non-ARD controls (54% vs. 41.2%, p = 0.7886), and this was also similar in > 12 weeks post-acute COVID-19 (68.3% vs. 88.2%, p = 0.1322). Further analysis of the risk factors for ≥ 4 weeks post-acute COVID-19 in ARD patients revealed that age, sex, clinical severity of COVID-19, reinfection, and autoimmune diseases were not associated with this condition (p > 0.05). The clinical manifestations of post-acute COVID-19 were similar in both groups (p > 0.05), with fatigue and memory loss being the most frequent manifestations. Conclusion We provide novel data demonstrating that immune/inflammatory ARD disturbances after third dose vaccination do not seem to be a major determinant of post-acute COVID-19 since its pattern is very similar to that of the general population. Clinical Trials platform (NCT04754698).
6.
COVID-19 in otolaryngologists: a cross-sectional multicenter study COVID19 COVID 19 COVID-1 otolaryngologists crosssectional cross sectional COVID1 1 COVID-
Facebook Twitter

Facebook Twitter
- Outras redes sociais
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Outras redes
- Métricas
Scapini, Fabrício
; Lubianca Neto, José Faibes
; Angeli, Roberto Dihl
; Krumenauer, Rita Carolina Pozzer
; Santanna, Ingrid Wendland
; Oppermann, Luciana Pimentel
; Atolini Junior, Nedio
; Meotti, Camila Degen
; Elias, Caroline Catherine Lacerda
; Medeiros, Lilcia Helena de Britto
; Roithmann, Renato
; Castagno, Clarissa Delpizzo
; Carli, Adriana de
; Granzotto, Eduardo Homrich
; Steffen, Nedio
; Maahs, Gerson Schulz
.
















Abstract Introduction: The nose and throat are areas of high viral load, which could place otolaryngologists at an even higher risk for COVID-19 than other health-care workers. Objective: To investigate the prevalence of antibodies against SARS-CoV-2 in otorhinolaryngologists in southern Brazil, its relationship to demographic data, professional practice and reported symptoms of COVID-19, and compare it with official data on other health-care workers of the state and the general population in the same period. Methods: In this cross-sectional multicenter study, otolaryngologists actively practicing officially registered in Rio Grande do Sul were screened for IgM and IgG antibodies against SARS-CoV-2 from August 1 to September 15, 2020. A questionnaire was also applied. Results: We screened 358 (80.1%) of 447 actively practicing otolaryngologists (195 [54.5%] male; mean [SD] age, 47.77 [13.57] years; range, 26-84 years). Twenty-three were positive for IgM and/or IgG (6.4%). This result was significantly associated with reports of infected household contacts (19/315 negatives and 8/23 positives; p<0.001). From 23 seropositive participants, 14 were asymptomatic (60.9%; p< 0.001). There were no significant associations between seroconversion and age, sex, number of patient appointments and surgical procedures, workplace (hospital or private practice), patients with or without respiratory symptoms, or level of personal protective equipment used. The rate of COVID-19 in all health-care workers in the state was 7.69% at the end of the same period. Data from state government seroprevalence was 5.26 (risk ratio [RR]; 95% CI 3.27–8.45) and 4.66 (RR; 95% CI 2.93–7.43) times higher in otolaryngologists than in the general population in August and September, respectively. Conclusion: Otolaryngologists had a higher seroconversion rate than the general population. Using personal protective equipment, the level of occupational exposure did not result in higher rates of infection than other health-care workers, but the presence of infected household contacts was associated with higher rates of seroconversion. Introduction load COVID19 COVID 19 COVID-1 healthcare health care Objective SARSCoV2 SARSCoV SARS CoV 2 SARS-CoV- Brazil COVID19, 19, period Methods crosssectional cross sectional study 15 2020 applied Results 35 80.1% 801 80 (80.1% 44 195 (19 54.5% 545 54 5 [54.5% male SD [SD age 4777 47 77 47.7 13.57 1357 13 57 [13.57 years range 2684 26 84 26-8 years. . years) Twentythree Twenty three andor 6.4%. 64 6.4% 6 4 (6.4%) 19/315 19315 315 (19/31 823 8 8/2 positives p<0.001. p0001 p p<0.001 0 001 p<0.001) participants 60.9% 609 60 9 (60.9% 0.001. 0001 0.001 0.001) sex procedures hospital practice, , practice) used 769 7 69 7.69 526 5.2 RR [RR] 95 3.27–8.45 327845 3 27 45 466 66 4.6 (RR 2.93–7.43 293743 93 43 respectively Conclusion COVID1 COVID- SARS-CoV 202 80.1 (80.1 (1 54.5 [54.5 477 47. 13.5 135 [13.5 268 26- 6.4 (6.4% 19/31 1931 31 (19/3 82 8/ p000 p<0.00 00 60.9 (60.9 000 0.00 76 7.6 52 5. [RR 3.27–8.4 32784 46 4. 2.93–7.4 29374 20 80. (80. ( 54. [54. 13. [13. 6. (6.4 19/3 193 (19/ p00 p<0.0 60. (60. 0.0 7. 3.27–8. 3278 2.93–7. 2937 (80 [54 [13 (6. 19/ p0 p<0. (60 0. 3.27–8 327 2.93–7 293 (8 [5 [1 (6 p<0 3.27– 32 2.93– 29 [ 3.27 2.93 3.2 2.9 3. 2.
7.
IMPACTO-MR: um estudo brasileiro de plataforma nacional para avaliar infecções e multirresistência em unidades de terapia intensiva IMPACTOMR IMPACTO MR IMPACTO-MR
Facebook Twitter

Facebook Twitter
- Outras redes sociais
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Outras redes
- Métricas
Tomazini, Bruno M
; Nassar Jr, Antonio Paulo
; Lisboa, Thiago Costa
; Azevedo, Luciano César Pontes de
; Veiga, Viviane Cordeiro
; Catarino, Daniela Ghidetti Mangas
; Fogazzi, Debora Vacaro
; Arns, Beatriz
; Piastrelli, Filipe Teixeira
; Dietrich, Camila
; Negrelli, Karina Leal
Jesuíno, Isabella de Andrade
Reis, Luiz Fernando Lima
Mattos, Renata Rodrigues de
Pinheiro, Carla Cristina Gomes
Luz, Mariane Nascimento
Spadoni, Clayse Carla da Silva
Moro, Elisângela Emilene
Bueno, Flávia Regina
Sampaio, Camila Santana Justo Cintra
Silva, Débora Patrício
Baldassare, Franca Pellison
Silva, Ana Cecilia Alcantara
Veiga, Thabata
Barbante, Leticia
Lambauer, Marianne
Campos, Viviane Bezerra
Santos, Elton
Santos, Renato Hideo Nakawaga
Laranjeiras, Ligia Nasi
Valeis, Nanci
Santucci, Eliana
Miranda, Tamiris Abait
Patrocínio, Ana Cristina Lagoeiro do
Carvalho, Andréa de
Sousa, Eduvirgens Maria Couto de
Sousa, Ancelmo Honorato Ferraz de
Malheiro, Daniel Tavares
Bezerra, Isabella Lott
Rodrigues, Mirian Batista
Malicia, Julliana Chicuta
Silva, Sabrina Souza da
Gimenes, Bruna dos Passos
Sesin, Guilhermo Prates
Zavascki, Alexandre Prehn
Sganzerla, Daniel
Medeiros, Gregory Saraiva
Santos, Rosa da Rosa Minho dos
Silva, Fernanda Kelly Romeiro
Cheno, Maysa Yukari
Abrahão, Carolinne Ferreira
Oliveira Junior, Haliton Alves de
Rocha, Leonardo Lima
Nunes Neto, Pedro Aniceto
Pereira, Valéria Chagas
Paciência, Luis Eduardo Miranda
Bueno, Elaine Silva
Caser, Eliana Bernadete
Ribeiro, Larissa Zuqui
Fernandes, Caio Cesar Ferreira
Garcia, Juliana Mazzei
Silva, Vanildes de Fátima Fernandes
Santos, Alisson Junior dos
Machado, Flávia Ribeiro
Souza, Maria Aparecida de
Ferronato, Bianca Ramos
Urbano, Hugo Corrêa de Andrade
Moreira, Danielle Conceição Aparecida
Souza-Dantas, Vicente Cés de
Duarte, Diego Meireles
Coelho, Juliana
Figueiredo, Rodrigo Cruvinel
Foreque, Fernanda
Romano, Thiago Gomes
Cubos, Daniel
Spirale, Vladimir Miguel
Nogueira, Roberta Schiavon
Maia, Israel Silva
Zandonai, Cassio Luis
Lovato, Wilson José
Cerantola, Rodrigo Barbosa
Toledo, Tatiana Gozzi Pancev
Tomba, Pablo Oscar
Almeida, Joyce Ramos de
Sanches, Luciana Coelho
Pierini, Leticia
Cunha, Mariana
Sousa, Michelle Tereza
Azevedo, Bruna
Dal-Pizzol, Felipe
Damasio, Danusa de Castro
Bainy, Marina Peres
Beduhn, Dagoberta Alves Vieira
Jatobá, Joana D’Arc Vila Nova
Moura, Maria Tereza Farias de
Rego, Leila Rezegue de Moraes
Silva, Adria Vanessa da
Oliveira, Luana Pontes
Sodré Filho, Eliene Sá
Santos, Silvana Soares dos
Neves, Itallo de Lima
Leão, Vanessa Cristina de Aquino
Paes, João Lucidio Lobato
Silva, Marielle Cristina Mendes
Oliveira, Cláudio Dornas de
Santiago, Raquel Caldeira Brant
Paranhos, Jorge Luiz da Rocha
Wiermann, Iany Grinezia da Silva
Pedroso, Durval Ferreira Fonseca
Sawada, Priscilla Yoshiko
Prestes, Rejane Martins
Nascimento, Glícia Cardoso
Grion, Cintia Magalhães Carvalho
Carrilho, Claudia Maria Dantas de Maio
Dantas, Roberta Lacerda Almeida de Miranda
Silva, Eliane Pereira
Silva, Antônio Carlos da
Oliveira, Sheila Mara Bezerra de
Golin, Nicole Alberti
Tregnago, Rogerio
Lima, Valéria Paes
Silva, Kamilla Grasielle Nunes da
Boschi, Emerson
Buffon, Viviane
Machado, André Sant’Ana
Capeletti, Leticia
Foernges, Rafael Botelho
Carvalho, Andréia Schubert de
Oliveira Junior, Lúcio Couto de
Oliveira, Daniela Cunha de
Silva, Everton Macêdo
Ribeiro, Julival
Pereira, Francielle Constantino
Salgado, Fernanda Borges
Deutschendorf, Caroline
Silva, Cristofer Farias da
Gobatto, Andre Luiz Nunes
Oliveira, Carolaine Bomfim de
Dracoulakis, Marianna Deway Andrade
Alvaia, Natália Oliveira Santos
Souza, Roberta Machado de
Araújo, Larissa Liz Cardoso de
Melo, Rodrigo Morel Vieira de
Passos, Luiz Carlos Santana
Vidal, Claudia Fernanda de Lacerda
Rodrigues, Fernanda Lopes de Albuquerque
Kurtz, Pedro
Shinotsuka, Cássia Righy
Tavares, Maria Brandão
Santana, Igor das Virgens
Gavinho, Luciana Macedo da Silva
Nascimento, Alaís Brito
Pereira, Adriano J
Cavalcanti, Alexandre Biasi










Revista Brasileira de Terapia Intensiva
- Métricas do periódico
RESUMO Objetivo: Descrever o IMPACTO-MR, um estudo brasileiro de plataforma nacional em unidades de terapia intensiva focado no impacto das infecções por bactérias multirresistentes relacionadas à assistência à saúde. Métodos: Descrevemos a plataforma IMPACTO-MR, seu desenvolvimento, critérios para seleção das unidades de terapia intensiva, caracterização da coleta de dados, objetivos e projetos de pesquisa futuros a serem realizados na plataforma. Resultados: Os dados principais foram coletados por meio do Epimed Monitor System® e consistiram em dados demográficos, dados de comorbidades, estado funcional, escores clínicos, diagnóstico de internação e diagnósticos secundários, dados laboratoriais, clínicos e microbiológicos e suporte de órgãos durante a internação na unidade de terapia intensiva, entre outros. De outubro de 2019 a dezembro de 2020, 33.983 pacientes de 51 unidades de terapia intensiva foram incluídos no banco de dados principal. Conclusão: A plataforma IMPACTO-MR é um banco de dados clínico brasileiro de unidades de terapia intensiva focado na pesquisa do impacto das infecções por bactérias multirresistentes relacionadas à assistência à saúde. Essa plataforma fornece dados para o desenvolvimento e pesquisa de unidades de terapia intensiva individuais e ensaios clínicos observacionais e prospectivos multicêntricos. Objetivo IMPACTOMR, IMPACTOMR IMPACTO MR, MR saúde Métodos Resultados System demográficos comorbidades funcional secundários laboratoriais outros 201 2020 33983 33 983 33.98 5 principal Conclusão multicêntricos 20 202 3398 3 98 33.9 2 339 9 33.
ABSTRACT Objective: To describe the IMPACTO-MR, a Brazilian nationwide intensive care unit platform study focused on the impact of health care-associated infections due to multidrug-resistant bacteria. Methods: We described the IMPACTO-MR platform, its development, criteria for intensive care unit selection, characterization of core data collection, objectives, and future research projects to be held within the platform. Results: The core data were collected using the Epimed Monitor System® and consisted of demographic data, comorbidity data, functional status, clinical scores, admission diagnosis and secondary diagnoses, laboratory, clinical, and microbiological data, and organ support during intensive care unit stay, among others. From October 2019 to December 2020, 33,983 patients from 51 intensive care units were included in the core database. Conclusion: The IMPACTO-MR platform is a nationwide Brazilian intensive care unit clinical database focused on researching the impact of health care-associated infections due to multidrug-resistant bacteria. This platform provides data for individual intensive care unit development and research and multicenter observational and prospective trials. Objective IMPACTOMR, IMPACTOMR IMPACTO MR, MR careassociated associated multidrugresistant multidrug resistant bacteria Methods selection collection objectives Results System status scores diagnoses laboratory stay others 201 2020 33983 33 983 33,98 5 Conclusion trials 20 202 3398 3 98 33,9 2 339 9 33,
8.
Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task force
Facebook Twitter

Facebook Twitter
- Outras redes sociais
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Outras redes
- Métricas
Tavares, Anna Carolina Faria Moreira Gomes
; Melo, Ana Karla Guedes de
Cruz, Vítor Alves
Souza, Viviane Angelina de
Carvalho, Joana Starling de
Machado, Ketty Lysie Libardi Lira
Valadares, Lilian David de Azevedo
Reis Neto, Edgard Torres dos
Rezende, Rodrigo Poubel Vieira de
Guimarães, Maria Fernanda Brandão de Resende
Ferreira, Gilda Aparecida
Braz, Alessandra de Sousa
Vieira, Rejane Maria Rodrigues de Abreu
Pinheiro, Marcelo de Medeiros
Ribeiro, Sandra Lúcia Euzébio
Bica, Blanca Elena Gomes Rios
Baptista, Kátia Lino
Costa, Izaias Pereira da
Marques, Claudia Diniz Lopes
Lopes, Maria Lúcia Lemos
Martinez, José Eduardo
Giorgi, Rina Dalva Neubarth
Mota, Lícia Maria Henrique da
Loures, Marcos Antônio Araújo da Rocha
Paiva, Eduardo dos Santos
Monticielo, Odirlei André
Xavier, Ricardo Machado
Kakehasi, Adriana Maria
Pileggi, Gecilmara Cristina Salviato

Abstract Objective: To provide guidelines on the coronavirus disease 2019 (COVID-19) vaccination in patients with immune-mediated rheumatic diseases (IMRD) to rheumatologists considering specific scenarios of the daily practice based on the shared-making decision (SMD) process. Methods: A task force was constituted by 24 rheumatologists (panel members), with clinical and research expertise in immunizations and infectious diseases in immunocompromised patients, endorsed by the Brazilian Society of Rheumatology (BSR), to develop guidelines for COVID-19 vaccination in patients with IMRD. A consensus was built through the Delphi method and involved four rounds of anonymous voting, where five options were used to determine the level of agreement (LOA), based on the Likert Scale: (1) strongly disagree; (2) disagree, (3) neither agree nor disagree (neutral); (4) agree; and (5) strongly agree. Nineteen questions were addressed and discussed via teleconference to formulate the answers. In order to identify the relevant data on COVID-19 vaccines, a search with standardized descriptors and synonyms was performed on September 10th, 2021, of the MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, ClinicalTrials.gov, and LILACS to identify studies of interest. We used the Newcastle–Ottawa Scale to assess the quality of nonrandomized studies. Results: All the nineteen questions-answers (Q&A) were approved by the BSR Task Force with more than 80% of panelists voting options 4—agree—and 5—strongly agree—, and a consensus was reached. These Guidelines were focused in SMD on the most appropriate timing for IMRD patients to get vaccinated to reach the adequate covid-19 vaccination response. Conclusion: These guidelines were developed by a BSR Task Force with a high LOA among panelists, based on the literature review of published studies and expert opinion for COVID-19 vaccination in IMRD patients. Noteworthy, in the pandemic period, up to the time of the review and the consensus process for this document, high-quality evidence was scarce. Thus, it is not a substitute for clinical judgment.
9.
Factors associated with hospitalizations for Covid-19 in patients with rheumatoid arthritis: data from the Reumacov Brazil registry
Facebook Twitter

Facebook Twitter
- Outras redes sociais
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Outras redes
- Métricas
Gomides, Ana Paula Monteiro
; Albuquerque, Cleandro Pires de
Mota, Licia Maria Henrique da
Devidé, Guilherme
Dias, Laiza Hombre
Duarte, Angela Luzia Branco Pinto
Giovelli, Raquel Altoé
Karnopp, Thais Evelyn
Lima, Hugo Deleon de
Marinho, Adriana
Oliveira, Marianne Schrader de
Omura, Felipe
Ranzolin, Aline
Resende, Gustavo
Ribeiro, Francinne Machado
Ribeiro, Sandra Lúcia Euzébio
Sacilotto, Nathália de Carvalho
Santos, Wander Gonzaga dos
Shinjo, Samuel Katsuyuki
Studart, Samia Araujo de Sousa
Teixeira, Flávia Patricia Sena
Yazbek, Michel Alexandre
Ferreira, Gilda Aparecida
Monticielo, Odirlei A.
Paiva, Eduardo
Pileggi, Gecilmara Cristina Salviato
Reis Neto, Edgard Torres dos
Pinheiro, Marcelo de Medeiros
Marques, Claudia D. L.

Abstract Background: Patients using immunosuppressive drugs may have unfavorable results after infections. However, there is a lack of information regarding COVID 19 in these patients, especially in patients with rheumatoid arthritis (RA). Therefore, the aim of this study was to evaluate the risk factors associated with COVID 19 hospitalizations in patients with RA. Methods: This multicenter, prospective cohort study is within the ReumaCoV Brazil registry and included 489 patients with RA. In this context, 269 patients who tested positive for COVID 19 were compared to 220 patients who tested negative for COVID 19 (control group). All patient data were collected from the Research Electronic Data Capture database. Results: The participants were predominantly female (90.6%) with a mean age of 53 ±12 years. Of the patients with COVID 19, 54 (20.1%) required hospitalization. After multiple adjustments, the final regression model showed that heart disease (OR =4.61, 95% CI 1.06–20.02. P < 0.001) and current use of glucocorticoids (OR =20.66, 95% CI 3.09–138. P < 0.002) were the risk factors associated with hospitalization. In addition, anosmia was associated with a lower chance of hospitalization (OR =0.26; 95% CI 0.10–0.67, P < 0.005). Conclusion: Our results demonstrated that heart disease and the use of glucocorticoids were associated with a higher number of hospital admissions for COVID 19 in patients with RA. Trial registration: Brazilian Registry of Clinical Trials RBR 33YTQC.
10.
COVID-19 in the Perioperative Period of Cardiovascular Surgery: the Brazilian Experience
Facebook Twitter

Facebook Twitter
- Outras redes sociais
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Outras redes
- Métricas
Gomes, Walter J.
; Rocco, Isadora
Pimentel, Wallace S.
Pinheiro, Aislan H. B.
Souza, Paulo M. S.
Costa, Luiz A. A.
Teixeira, Marjory M. P.
Ohashi, Leonardo P.
Bublitz, Caroline
Begot, Isis
Moreira, Rita Simone L
Hossne Jr, Nelson A.
Vargas, Guilherme F.
Branco, João Nelson R.
Teles, Carlos A.
Medeiros, Eduardo A. S.
Sáfadi, Camila
Rampinelli, Amândio
Moratelli Neto, Leopoldo
Rosado, Anderson Rosa
Mesacasa, Franciele Kuhn
Capriata, Ismael Escobar
Segalote, Rodrigo Coelho
Palmieri, Deborah Louize da Rocha Vianna
Jardim, Amanda Cristina Mendes
Vianna, Diego Sarty
Coutinho, Joaquim Henrique de Souza Aguiar
Jazbik, João Carlos
Coutinho, Henrique Madureira da Rocha
Kikuta, Gustavo
Almeida, Zely Sant'Anna Marotti de
Feguri, Gibran Roder
Lima, Paulo Ruiz Lucio de
Franco, Anna Carolina
Borges, Danilo de Cerqueira
Cruz, Felipe Ramos Honorato De La
Croti, Ulisses Alexandre
Borim, Bruna Cury
Marchi, Carlos Henrique De
Goraieb, Lilian
Postigo, Karolyne Barroca Sanches
Jucá, Fabiano Gonçalves
Oliveira, Fátima Rosane de Almeida
Souza, Rafael Bezerra de
Zilli, Alexandre Cabral
Mas, Raul Gaston Sanchez
Bettiati Junior, Luiz Carlos
Tranchesi, Ricardo
Bertini Jr, Ayrton
Franco, Leandro Vieira
Fernandes, Priscila
Oliveira, Fabiana
Moraes Jr, Roberto
Araújo, Thiago Cavalcanti Vila Nova de
Braga, Otávio Penna
Pedrosa Sobrinho, Antônio Cavalcanti
Teixeira, Roberta Tavares Barreto
Camboim, Irla Lavor Lucena
Gomes, Eduardo Nascimento
Reis, Pedro Horigushi
Garcia, Luara Piovan
Scorsioni, Nelson Henrique Goes
Lago, Roberto
Guizilini, Solange

Brazilian Journal of Cardiovascular Surgery
- Métricas do periódico
Abstract Introduction: We investigated the clinical course and outcomes of patients submitted to cardiovascular surgery in Brazil and who had developed symptoms/signs of coronavirus disease 2019 (COVID-19) in the perioperative period. Methods: A retrospective multicenter study including 104 patients who were allocated in three groups according to time of positive real time reverse transcriptase-polymerase chain reaction (RT-PCR) for the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2): group 1, patients who underwent cardiac surgery > 10 days after positive RT-PCR; group 2, patients with a positive RT-PCR within 10 days before or after surgery; group 3, patients who presented positive RT-PCR > 10 days after surgery. The primary outcome was mortality and secondary outcomes were postoperative complications, intensive care unit (ICU) length of stay, and postoperative days of hospitalization. Results: The three groups were similar with respect to age, the European System of Cardiac Operative Risk Evaluation score, and comorbidities, except hypertension. Postoperative complications and death were significantly higher in groups 2 and 3 than in group 1, and no significant difference between groups 2 and 3 was seen. Group 2 showed a high prevalence of surgery performed as an urgent procedure. Although no significant differences were observed in ICU length of stay, total postoperative hospitalization time was significantly higher in group 3 than in groups 1 and 2. Conclusion: COVID-19 affecting the postoperative period of patients who underwent cardiovascular surgery is associated with a higher rate of morbidity and mortality. Delaying procedures in RT-PCR-positive patients may help reduce risks of perioperative complications and death.
11.
Posicionamento Brasileiro sobre o Uso da Multimodalidade de Imagens na Cardio-Oncologia – 2021
Facebook Twitter

Facebook Twitter
- Outras redes sociais
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Outras redes
- Métricas
Melo, Marcelo Dantas Tavares de
; Paiva, Marcelo Goulart
; Santos, Maria Verônica Câmara
; Rochitte, Carlos Eduardo
; Moreira, Valéria de Melo
; Saleh, Mohamed Hassan
; Brandão, Simone Cristina Soares
; Gallafrio, Claudia Cosentino
; Goldwasser, Daniel
; Gripp, Eliza de Almeida
; Piveta, Rafael Bonafim
; Silva, Tonnison Oliveira
; Santo, Thais Harada Campos Espirito
; Ferreira, Waldinai Pereira
; Salemi, Vera Maria Cury
; Cauduro, Sanderson A.
; Barberato, Silvio Henrique
; Lopes, Heloísa M. Christovam
; Pena, José Luiz Barros
; Rached, Heron Rhydan Saad
; Miglioranza, Marcelo Haertel
; Pinheiro, Aurélio Carvalho
; Vrandecic, Bárbara Athayde Linhares Martins
; Cruz, Cecilia Beatriz Bittencourt Viana
; Nomura, César Higa
; Cerbino, Fernanda Mello Erthal
; Costa, Isabela Bispo Santos da Silva
; Coelho Filho, Otavio Rizzi
; Carneiro, Adriano Camargo de Castro
; Burgos, Ursula Maria Moreira Costa
Fernandes, Juliano Lara
Uellendahl, Marly
Calado, Eveline Barros
Senra, Tiago
Assunção, Bruna Leal
Freire, Claudia Maria Vilas
Martins, Cristiane Nunes
Sawamura, Karen Saori Shiraishi
Brito, Márcio Miranda
Jardim, Maria Fernanda Silva
Bernardes, Renata Junqueira Moll
Diógenes, Tereza Cristina
Vieira, Lucas de Oliveira
Mesquita, Claudio Tinoco
Lopes, Rafael Willain
Segundo Neto, Elry Medeiros Vieira
Rigo, Letícia
Marin, Valeska Leite Siqueira
Santos, Marcelo José
Grossman, Gabriel Blacher
Quagliato, Priscila Cestari
Alcantara, Monica Luiza de
Teodoro, José Aldo Ribeiro
Albricker, Ana Cristina Lopes
Barros, Fanilda Souto
Amaral, Salomon Israel do
Porto, Carmen Lúcia Lascasas
Barros, Marcio Vinícius Lins
Santos, Simone Nascimento dos
Cantisano, Armando Luís
Petisco, Ana Cláudia Gomes Pereira
Barbosa, José Eduardo Martins
Veloso, Orlando Carlos Glória
Spina, Salvador
Pignatelli, Ricardo
Hajjar, Ludhmilla Abrahão
Kalil Filho, Roberto
Lopes, Marcelo Antônio Cartaxo Queiroga
Vieira, Marcelo Luiz Campos
Almeida, André Luiz Cerqueira





























Arquivos Brasileiros de Cardiologia
- Métricas do periódico
https://doi.org/10.36660/abc.20200266
103 downloads
12.
Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil
Facebook Twitter

Facebook Twitter
- Outras redes sociais
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Outras redes
- Métricas
Pileggi, Gecilmara Salviato
; Ferreira, Gilda Aparecida
Gomides Reis, Ana Paula Monteiro
Reis Neto, Edgard Torres
Abreu, Mirhelen Mendes
Albuquerque, Cleandro Pires
Araújo, Nafice Costa
Bacchiega, Ana Beatriz
Bianchi, Dante Valdetaro
Bica, Blanca
Bonfa, Eloisa Duarte
Borba, Eduardo Ferreira
Brito, Danielle Christinne Soares Egypto
Duarte, Ângela Luzia Branco Pinto
Santo, Rafaela Cavalheiro Espírito
Fernandes, Paula Reale
Guimarães, Mariana Peixoto
Gomes, Kirla Wagner Poti
Kakehasi, Adriana Maria
Klumb, Evandro Mendes
Lanna, Cristina Costa Duarte
Marques, Claudia Diniz Lopes
Monticielo, Odirlei André
Mota, Licia Maria Henrique
Munhoz, Gabriela Araújo
Paiva, Eduardo Santos
Pereira, Helena Lucia Alves
Provenza, José Roberto
Ribeiro, Sandra Lucia Euzébio
Rocha Junior, Laurindo Ferreira
Sampaio, Camila Santana Justo Cintra
Sampaio, Vanderson Souza
Sato, Emília Inoue
Skare, Thelma
de Souza, Viviane Angelina
Valim, Valeria
Lacerda, Marcus Vinícius Guimarães
Xavier, Ricardo Machado
Pinheiro, Marcelo Medeiros

Abstract Background: There is a lack of information on the role of chronic use of hydroxychloroquine during the SARS-CoV-2 outbreak. Our aim was to compare the occurrence of COVID-19 between rheumatic disease patients on hydroxychloroquine with individuals from the same household not taking the drug during the first 8 weeks of community viral transmission in Brazil. Methods: This baseline cross-sectional analysis is part of a 24-week observational multi-center study involving 22 Brazilian academic outpatient centers. All information regarding COVID-19 symptoms, epidemiological, clinical, and demographic data were recorded on a specific web-based platform using telephone calls from physicians and medical students. COVID-19 was defined according to the Brazilian Ministry of Health (BMH) criteria. Mann-Whitney, Chi-square and Exact Fisher tests were used for statistical analysis and two binary Final Logistic Regression Model by Wald test were developed using a backward-stepwise method for the presence of COVID-19. Results: From March 29th to May 17st, 2020, a total of 10,443 participants were enrolled, including 5166 (53.9%) rheumatic disease patients, of whom 82.5% had systemic erythematosus lupus, 7.8% rheumatoid arthritis, 3.7% Sjögren’s syndrome and 0.8% systemic sclerosis. In total, 1822 (19.1%) participants reported flu symptoms within the 30 days prior to enrollment, of which 3.1% fulfilled the BMH criteria, but with no significant difference between rheumatic disease patients (4.03%) and controls (3.25%). After adjustments for multiple confounders, the main risk factor significantly associated with a COVID-19 diagnosis was lung disease (OR 1.63; 95% CI 1.03-2.58); and for rheumatic disease patients were diagnosis of systemic sclerosis (OR 2.8; 95% CI 1.19-6.63) and glucocorticoids above 10 mg/ day (OR 2.05; 95% CI 1.31-3.19). In addition, a recent influenza vaccination had a protective effect (OR 0.674; 95% CI 0.46-0.98). Conclusion: Patients with rheumatic disease on hydroxychloroquine presented a similar occurrence of COVID-19 to household cohabitants, suggesting a lack of any protective role against SARS-CoV-2 infection. Trial registration Brazilian Registry of Clinical Trials (ReBEC; RBR - 9KTWX6).
https://doi.org/10.1186/s42358-021-00217-0
22 downloads
13.
Doenças Crônicas Não Transmissíveis e fatores de risco e proteção em adultos com ou sem plano de saúde
Facebook Twitter

Facebook Twitter
- Outras redes sociais
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Outras redes
- Métricas
Malta, Deborah Carvalho
; Bernal, Regina Tomie Ivata
; Vieira Neto, Eduardo
; Curci, Kátia Audi
; Pasinato, Maria Tereza de Marsillac
; Lisbôa, Raquel Medeiros
; Cachapuz, Renata Fernandes
; Coelho, Karla Santa Cruz
; Santos, Fausto Pereira dos
; Freitas, Maria Imaculada Fátima de
.










Resumo O estudo descreve as coberturas de planos de saúde e compara a ocorrência de fatores de risco (FR) e proteção de Doenças Crônicas Não Transmissíveis, na população com e sem planos de saúde nas capitais brasileiras. Foram analisados dados do inquérito telefônico Vigitel. Foi utilizado o modelo de regressão de Poisson para estimar a razão de prevalência (RP), comparando FR entre quem tem ou não plano de saúde. A cobertura de planos foi de 49,1%, mais elevada em Goiania, Vitória, Florianópolis e Belo Horizonte, entre adultos acima de 55 anos e com maior escolaridade. A população com planos de saúde apresenta prevalências mais elevadas de fatores de proteção como consumo de frutas e hortaliças (RP = 1,3 IC95% 1,2-1,3), prática de atividade física no tempo livre (RP = 1,2 IC95% 1,2-1,3), mamografia (RP = 1,2 IC95% 1,1-1,3) e Papanicolau (RP = 1,1 IC95% 1,2-1,3), e menor prevalência de FR como tabagismo (RP = 0,7 IC95% 0,6-0,8), avaliação de saúde ruim (RP = 0,8 IC95% 0,6-0,9), obesidade (RP = 0,8 IC95% 0,7-0,9), carne com gordura (RP = 0,9 IC95% 0,8-0,9) e leite com gordura (RP = 0,9 IC95% 0,8-0,9). Independentemente da escolaridade, a população que tem planos de saúde apresenta geralmente, melhores indicadores, como hábitos mais saudáveis e maior cobertura de exames preventivos.
Abstract This study describes the coverage of health insurance and compares the occurrence of risk factors (RF) and protective factors of noncommunicable diseases in the population with and without health insurancesin Brazilianstate capitals. Data from the telephone survey Vigitel was analyzed. The Poisson regression model was used to estimate the prevalence ratio (PR), comparing RF among those who did or did not have a health insurance. Plan coverage was 49.1%, and the highest prevalences were in Goiania, Vitória, Florianópolis, and Belo Horizonte. Adults over 55 years of age and with higher education were more likely to have an insurance. The population with health insurance hada higher prevalence of protective factors, such as fruit and vegetable consumption (PR = 1.3 95% CI 1.2-1.3), physical activity in their free time (PR = 1.2 (95% CI: 1.2-1.3), mammographies (RP = 1.2 IC95% 1.1-1.3) and pap smears (PR = 1.1 IC95% 1.2-1.3), and lower prevalence of RFs such as smoking (RP = 0.7, 95% CI 0.6-0.8), poor health (RP = 0.8 CI95% 0.6-0.9), obesity (RP = 0.8 IC95% 0.7-0.9), consumption of meat with fat (RP = 0.9 IC95% 0.8-0.9) and whole milk (RP = 0.9 IC95% 0,8-0.9). Regardless of educational level, the population that has health insurancesgenerally has better indicators, such as healthier habits and greater coverage of preventive exams.
https://doi.org/10.1590/1413-81232020258.32762018
2727 downloads
14.
Doenças Crônicas Não Transmissíveis e fatores de risco e proteção em adultos com ou sem plano de saúde
Facebook Twitter

Facebook Twitter
- Outras redes sociais
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Outras redes
- Métricas
Malta, Deborah Carvalho
; Bernal, Regina Tomie Ivata
; Vieira Neto, Eduardo
; Curci, Kátia Audi
; Pasinato, Maria Tereza de Marsillac
; Lisbôa, Raquel Medeiros
; Cachapuz, Renata Fernandes
; Coelho, Karla Santa Cruz
; Santos, Fausto Pereira dos
; Freitas, Maria Imaculada Fátima de
.










Resumo O estudo descreve as coberturas de planos de saúde e compara a ocorrência de fatores de risco (FR) e proteção de Doenças Crônicas Não Transmissíveis, na população com e sem planos de saúde nas capitais brasileiras. Foram analisados dados do inquérito telefônico Vigitel. Foi utilizado o modelo de regressão de Poisson para estimar a razão de prevalência (RP), comparando FR entre quem tem ou não plano de saúde. A cobertura de planos foi de 49,1%, mais elevada em Goiania, Vitória, Florianópolis e Belo Horizonte, entre adultos acima de 55 anos e com maior escolaridade. A população com planos de saúde apresenta prevalências mais elevadas de fatores de proteção como consumo de frutas e hortaliças (RP = 1,3 IC95% 1,2-1,3), prática de atividade física no tempo livre (RP = 1,2 IC95% 1,2-1,3), mamografia (RP = 1,2 IC95% 1,1-1,3) e Papanicolau (RP = 1,1 IC95% 1,2-1,3), e menor prevalência de FR como tabagismo (RP = 0,7 IC95% 0,6-0,8), avaliação de saúde ruim (RP = 0,8 IC95% 0,6-0,9), obesidade (RP = 0,8 IC95% 0,7-0,9), carne com gordura (RP = 0,9 IC95% 0,8-0,9) e leite com gordura (RP = 0,9 IC95% 0,8-0,9). Independentemente da escolaridade, a população que tem planos de saúde apresenta geralmente, melhores indicadores, como hábitos mais saudáveis e maior cobertura de exames preventivos.
Abstract This study describes the coverage of health insurance and compares the occurrence of risk factors (RF) and protective factors of noncommunicable diseases in the population with and without health insurancesin Brazilianstate capitals. Data from the telephone survey Vigitel was analyzed. The Poisson regression model was used to estimate the prevalence ratio (PR), comparing RF among those who did or did not have a health insurance. Plan coverage was 49.1%, and the highest prevalences were in Goiania, Vitória, Florianópolis, and Belo Horizonte. Adults over 55 years of age and with higher education were more likely to have an insurance. The population with health insurance hada higher prevalence of protective factors, such as fruit and vegetable consumption (PR = 1.3 95% CI 1.2-1.3), physical activity in their free time (PR = 1.2 (95% CI: 1.2-1.3), mammographies (RP = 1.2 IC95% 1.1-1.3) and pap smears (PR = 1.1 IC95% 1.2-1.3), and lower prevalence of RFs such as smoking (RP = 0.7, 95% CI 0.6-0.8), poor health (RP = 0.8 CI95% 0.6-0.9), obesity (RP = 0.8 IC95% 0.7-0.9), consumption of meat with fat (RP = 0.9 IC95% 0.8-0.9) and whole milk (RP = 0.9 IC95% 0,8-0.9). Regardless of educational level, the population that has health insurancesgenerally has better indicators, such as healthier habits and greater coverage of preventive exams.
15.
Neurological consultations and diagnoses in a large, dedicated COVID-19 university hospital
Facebook Twitter

Facebook Twitter
- Outras redes sociais
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Outras redes
- Métricas
STUDART-NETO, Adalberto
; GUEDES, Bruno Fukelmann
; TUMA, Raphael de Luca e
; CAMELO FILHO, Antonio Edvan
; KUBOTA, Gabriel Taricani
; IEPSEN, Bruno Diógenes
; MOREIRA, Gabriela Pantaleão
; RODRIGUES, Júlia Chartouni
; FERRARI, Maíra Medeiros Honorato
; CARRA, Rafael Bernhart
; SPERA, Raphael Ribeiro
; OKU, Mariana Hiromi Manoel
; TERRIM, Sara
; LOPES, Cesar Castello Branco
; PASSOS NETO, Carlos Eduardo Borges
; FIORENTINO, Matheus Dalben
; DE SOUZA, Julia Carvalhinho Carlos
; BAIMA, José Pedro Soares
; DA SILVA, Tomás Fraga Ferreira
; MORENO, Cristiane Araujo Martins
; SILVA, Andre Macedo Serafim
; HEISE, Carlos Otto
; MENDONÇA, Rodrigo Holanda
; FORTINI, Ida
; SMID, Jerusa
; ADONI, Tarso
; GONÇALVES, Marcia Rubia Rodrigues
; PEREIRA, Samira Luisa Apóstolos
; PINTO, Lecio Figueira
; GOMES, Helio Rodrigues
; ZANOTELI, Edmar
; BRUCKI, Sonia Maria Dozzi
; CONFORTO, Adriana Bastos
; CASTRO, Luiz Henrique Martins
; NITRINI, Ricardo
.



































RESUMO Introdução: Mais de um terço dos pacientes com COVID-19 apresentam sintomas neurológicos que variam de anosmia a AVC e encefalopatia. Além disso, doenças neurológicas prévias podem exigir tratamento especial e estar associadas a piores desfechos. Não obstante, o papel dos neurologistas na COVID-19 é provavelmente pouco reconhecido. Objetivo: O objetivo deste estudo foi relatar os motivos para solicitar consultas neurológicas por clínicos e intensivistas em um hospital dedicado à COVID-19. Métodos: Estudo retrospectivo realizado no Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Brasil, um centro dedicado à COVID-19 com 900 leitos (incluindo 300 leitos para unidades de terapia intensiva). O diagnóstico de COVID-19 foi confirmado por SARS-CoV-2-RT-PCR em swabs nasais. Todas as interconsultas de neurologia hospitalar entre 23 de março e 23 de maio de 2020 foram analisadas. Os neurologistas realizaram o exame neurológico, avaliaram todos os dados disponíveis para diagnosticar a patologia neurológica e solicitaram exames adicionais conforme necessidade. Diagnósticos difíceis foram estabelecidos em reuniões de consenso. Após o diagnóstico, os neurologistas participaram da condução dos casos. Resultados: Foram solicitadas consultas neurológicas para 89 de 1.208 (7,4%) em pacientes internados por COVID-19 durante o período. Os principais diagnósticos neurológicos incluíram: encefalopatia (44,4%), acidente vascular cerebral (16,7%), doenças neurológicas prévias (9,0%), crises epilépticas (9,0%), transtornos neuromusculares (5,6%), outras lesões encefálicas agudas (3,4%) e outros sintomas leves inespecíficos (11,2%). Conclusões: A maioria das consultas neurológicas em um hospital dedicado à COVID-19 foi solicitada para condições graves que poderiam afetar o desfecho clínico. Os médicos na linha de frente devem ser capazes de reconhecer sintomas neurológicos. Os neurologistas são membros importantes da equipe médica no atendimento hospitalar à COVID-19.
ABSTRACT Background: More than one-third of COVID-19 patients present neurological symptoms ranging from anosmia to stroke and encephalopathy. Furthermore, pre-existing neurological conditions may require special treatment and may be associated with worse outcomes. Notwithstanding, the role of neurologists in COVID-19 is probably underrecognized. Objective: The aim of this study was to report the reasons for requesting neurological consultations by internists and intensivists in a COVID-19-dedicated hospital. Methods: This retrospective study was carried out at Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Brazil, a 900-bed COVID-19 dedicated center (including 300 intensive care unit beds). COVID-19 diagnosis was confirmed by SARS-CoV-2-RT-PCR in nasal swabs. All inpatient neurology consultations between March 23rd and May 23rd, 2020 were analyzed. Neurologists performed the neurological exam, assessed all available data to diagnose the neurological condition, and requested additional tests deemed necessary. Difficult diagnoses were established in consensus meetings. After diagnosis, neurologists were involved in the treatment. Results: Neurological consultations were requested for 89 out of 1,208 (7.4%) inpatient COVID admissions during that period. Main neurological diagnoses included: encephalopathy (44.4%), stroke (16.7%), previous neurological diseases (9.0%), seizures (9.0%), neuromuscular disorders (5.6%), other acute brain lesions (3.4%), and other mild nonspecific symptoms (11.2%). Conclusions: Most neurological consultations in a COVID-19-dedicated hospital were requested for severe conditions that could have an impact on the outcome. First-line doctors should be able to recognize neurological symptoms; neurologists are important members of the medical team in COVID-19 hospital care.
https://doi.org/10.1590/0004-282x20200089
2651 downloads
Exibindo
itens por página
Página
de 3
Próxima
Visualizar estatísticas de
Enviar resultado
Exportar resultados
Sem resultados
Não foram encontrados documentos para sua pesquisa
Glossário e ajuda para busca
Você pode enriquecer sua busca de uma forma muito simples. Use os índices de pesquisa combinados com os conectores (AND ou OR) e especifique cada vez mais sua busca.
Por exemplo, se você deseja buscar artigos sobre
casos de dengue no Brasil em 2015, use:ti:dengue and publication_year:2015 and aff_country:Brasil
Veja abaixo a lista completa de índices de pesquisa que podem ser usados:
Cód. do Índice | Elemento |
---|---|
ti | título do artigo |
au | autor |
kw | palavras-chave do artigo |
subject | assunto (palavras do título, resumo e palavras-chave) |
ab | resumo |
ta | título abreviado da revista (ex. Cad. Saúde Pública) |
journal_title | título completo da revista (ex. Cadernos de Saúde Pública) |
la | código do idioma da publicação (ex. pt - Português, es - Espanhol) |
type | tipo do documento |
pid | identificador da publicação |
publication_year | ano de publicação do artigo |
sponsor | financiador |
aff_country | código do país de afiliação do autor |
aff_institution | instituição de afiliação do autor |
volume | volume do artigo |
issue | número do artigo |
elocation | elocation |
doi | número DOI |
issn | ISSN da revista |
in | código da coleção SciELO (ex. scl - Brasil, col - Colômbia) |
use_license | código da licença de uso do artigo |